抗ウイルス剤併用療法の世界市場レポート（2024年）

レポートナンバー　0000037427

抗ウイルス剤併用療法の世界市場レポート（2024年）

The Business Research Company

Antiviral Combination Therapy Global Market Report 2024

発刊日 2024/01/19

言語英語

体裁PDF/200ページ

ライセンス/価格200ページ

0000037427

Single	5,000USD
Site	7,500USD
Enterprise	10,000USD

※ご請求は、お申込日のTTSレートで円換算し、消費税を加えた金額になります。
※本レポートは、英文です。PDF(電子媒体)での納品となります。
※受注後、レポートは最新版へ更新されますので、納品までに3〜5営業日かかります。

お問い合わせ

サンプル依頼

無料サンプル

サンプルはお問い合わせください。

レポート概要

本レポートは、抗ウイルス剤併用療法の世界市場に関して、戦略家、マーケティング担当者、上級管理職が市場を評価するために必要な重要情報を提供します。

本レポートは、力強い成長を遂げている抗ウイルス剤併用療法市場に焦点を当て、今後10年およびそれ以降の市場を形成するトレンドについてのガイドを提供します。

調査範囲

調査市場
➣ タイプ別
　　◇ ブランド
　　◇ ジェネリック
➣ 薬剤併用別
　　◇ ヌクレオチド逆転写酵素阻害薬/非ヌクレオチド逆転写酵素阻害薬
　　◇ インテグラーゼ阻害薬/ヌクレオチド逆転写酵素阻害薬
　　◇ ヌクレオチド逆転写酵素阻害薬
　　◇ ヌクレオチド逆転写酵素阻害薬/プロテアーゼ阻害薬
　　◇ その他の薬剤併用
➣ 投与経路別
　　◇ 経口
　　◇ 静脈内
➣ 流通チャネル別
　　◇ 病院薬局
　　◇ 小売薬局
　　◇ その他の流通チャネル
➣ 適応症別
　　◇ ヒト免疫不全ウイルス
　　◇ 肝炎
　　◇ その他の適応症
調査企業
➣ AbbVie Inc.
➣ Bristol-Myers Squibb Company
➣ Celltrion Inc.
➣ Cipla Inc.
➣ F. Hoffmann-La Roche Ltd.
調査国
オーストラリア、ブラジル、中国、フランス、ドイツ、インド、インドネシア、日本、ロシア、韓国、イギリス、アメリカ、カナダ、イタリア、スペイン
調査地域
➣ アジア太平洋地域
➣ 西ヨーロッパ
➣ 東ヨーロッパ
➣ 北アメリカ
➣ 南アメリカ
➣ 中東
➣ アフリカ
調査期間
➣ 5年間の実績データおよび10年間の予測
データ
➣ 市場規模と成長率の関連市場に対する比率
➣ GDP比率
➣ 一人当たりの支出
データセグメント
➣ 国別・地域別の実績および予測データ
➣ 競合企業の市場シェア
➣ 市場セグメント
情報源および参照
➣ 本レポートのデータおよび分析は、注釈で出典を明らかにしています。
提供形態
➣ PDF、Word、Excelデータダッシュボード

レポート詳細

5. Global Antiviral Combination Therapy Market Size and Growth
5.1. Global Antiviral Combination Therapy Market Drivers and Restraints
5.1.1. Drivers Of The Market
5.1.2. Restraints Of The Market
5.2. Global Antiviral Combination Therapy Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
5.3. Global Antiviral Combination Therapy Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Antiviral Combination Therapy Market Segmentation
6.1. Global Antiviral Combination Therapy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Branded
Generic
6.2. Global Antiviral Combination Therapy Market, Segmentation By Drug Combination, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Nucleotide Reverse Transcriptase Inhibitors/Non-Nucleotide Reverse Transcriptase Inhibitors
Integrase Inhibitor/Nucleotide Reverse Transcriptase Inhibitors
Nucleotide Reverse Transcriptase Inhibitors
Nucleotide Reverse Transcriptase Inhibitors/Protease Inhibitor
Other Drug Combinations
6.3. Global Antiviral Combination Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Oral
Intravenous
6.4. Global Antiviral Combination Therapy Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Hospital Pharmacies
Retail Pharmacies
Other Distribution Channels
6.5. Global Antiviral Combination Therapy Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Human Immunodeficiency Virus
Hepatitis
Other Indications

7. Antiviral Combination Therapy Market Regional And Country Analysis
7.1. Global Antiviral Combination Therapy Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
7.2. Global Antiviral Combination Therapy Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Antiviral Combination Therapy Market
8.1. Asia-Pacific Antiviral Combination Therapy Market Overview
Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Antiviral Combination Therapy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.3. Asia-Pacific Antiviral Combination Therapy Market, Segmentation By Drug Combination, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.4. Asia-Pacific Antiviral Combination Therapy Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Antiviral Combination Therapy Market
9.1. China Antiviral Combination Therapy Market Overview
9.2. China Antiviral Combination Therapy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.3. China Antiviral Combination Therapy Market, Segmentation By Drug Combination, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.4. China Antiviral Combination Therapy Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Antiviral Combination Therapy Market
10.1. India Antiviral Combination Therapy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.2. India Antiviral Combination Therapy Market, Segmentation By Drug Combination, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.3. India Antiviral Combination Therapy Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Antiviral Combination Therapy Market
11.1. Japan Antiviral Combination Therapy Market Overview
11.2. Japan Antiviral Combination Therapy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.3. Japan Antiviral Combination Therapy Market, Segmentation By Drug Combination, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.4. Japan Antiviral Combination Therapy Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Antiviral Combination Therapy Market
12.1. Australia Antiviral Combination Therapy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.2. Australia Antiviral Combination Therapy Market, Segmentation By Drug Combination, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.3. Australia Antiviral Combination Therapy Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Antiviral Combination Therapy Market
13.1. Indonesia Antiviral Combination Therapy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.2. Indonesia Antiviral Combination Therapy Market, Segmentation By Drug Combination, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.3. Indonesia Antiviral Combination Therapy Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Antiviral Combination Therapy Market
14.1. South Korea Antiviral Combination Therapy Market Overview
14.2. South Korea Antiviral Combination Therapy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.3. South Korea Antiviral Combination Therapy Market, Segmentation By Drug Combination, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.4. South Korea Antiviral Combination Therapy Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Antiviral Combination Therapy Market
15.1. Western Europe Antiviral Combination Therapy Market Overview
15.2. Western Europe Antiviral Combination Therapy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.3. Western Europe Antiviral Combination Therapy Market, Segmentation By Drug Combination, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.4. Western Europe Antiviral Combination Therapy Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Antiviral Combination Therapy Market
16.1. UK Antiviral Combination Therapy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.2. UK Antiviral Combination Therapy Market, Segmentation By Drug Combination, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.3. UK Antiviral Combination Therapy Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Antiviral Combination Therapy Market
17.1. Germany Antiviral Combination Therapy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.2. Germany Antiviral Combination Therapy Market, Segmentation By Drug Combination, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.3. Germany Antiviral Combination Therapy Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Antiviral Combination Therapy Market
18.1. France Antiviral Combination Therapy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.2. France Antiviral Combination Therapy Market, Segmentation By Drug Combination, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.3. France Antiviral Combination Therapy Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Antiviral Combination Therapy Market
19.1. Italy Antiviral Combination Therapy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.2. Italy Antiviral Combination Therapy Market, Segmentation By Drug Combination, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.3. Italy Antiviral Combination Therapy Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Antiviral Combination Therapy Market
20.1. Spain Antiviral Combination Therapy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.2. Spain Antiviral Combination Therapy Market, Segmentation By Drug Combination, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.3. Spain Antiviral Combination Therapy Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Antiviral Combination Therapy Market
21.1. Eastern Europe Antiviral Combination Therapy Market Overview
21.2. Eastern Europe Antiviral Combination Therapy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.3. Eastern Europe Antiviral Combination Therapy Market, Segmentation By Drug Combination, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.4. Eastern Europe Antiviral Combination Therapy Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Antiviral Combination Therapy Market
22.1. Russia Antiviral Combination Therapy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.2. Russia Antiviral Combination Therapy Market, Segmentation By Drug Combination, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.3. Russia Antiviral Combination Therapy Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Antiviral Combination Therapy Market
23.1. North America Antiviral Combination Therapy Market Overview
23.2. North America Antiviral Combination Therapy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.3. North America Antiviral Combination Therapy Market, Segmentation By Drug Combination, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.4. North America Antiviral Combination Therapy Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Antiviral Combination Therapy Market
24.1. USA Antiviral Combination Therapy Market Overview
24.2. USA Antiviral Combination Therapy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.3. USA Antiviral Combination Therapy Market, Segmentation By Drug Combination, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.4. USA Antiviral Combination Therapy Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Antiviral Combination Therapy Market
25.1. Canada Antiviral Combination Therapy Market Overview
25.2. Canada Antiviral Combination Therapy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.3. Canada Antiviral Combination Therapy Market, Segmentation By Drug Combination, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.4. Canada Antiviral Combination Therapy Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Antiviral Combination Therapy Market
26.1. South America Antiviral Combination Therapy Market Overview
26.2. South America Antiviral Combination Therapy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.3. South America Antiviral Combination Therapy Market, Segmentation By Drug Combination, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.4. South America Antiviral Combination Therapy Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Antiviral Combination Therapy Market
27.1. Brazil Antiviral Combination Therapy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.2. Brazil Antiviral Combination Therapy Market, Segmentation By Drug Combination, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.3. Brazil Antiviral Combination Therapy Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Antiviral Combination Therapy Market
28.1. Middle East Antiviral Combination Therapy Market Overview
28.2. Middle East Antiviral Combination Therapy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.3. Middle East Antiviral Combination Therapy Market, Segmentation By Drug Combination, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.4. Middle East Antiviral Combination Therapy Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Antiviral Combination Therapy Market
29.1. Africa Antiviral Combination Therapy Market Overview
29.2. Africa Antiviral Combination Therapy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.3. Africa Antiviral Combination Therapy Market, Segmentation By Drug Combination, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.4. Africa Antiviral Combination Therapy Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Antiviral Combination Therapy Market Competitive Landscape And Company Profiles
30.1. Antiviral Combination Therapy Market Competitive Landscape
30.2. Antiviral Combination Therapy Market Company Profiles
30.2.1. AbbVie Inc.
30.2.1.1. Overview
30.2.1.2. Products and Services
30.2.1.3. Strategy
30.2.1.4. Financial Performance
30.2.2. Bristol-Myers Squibb Company
30.2.2.1. Overview
30.2.2.2. Products and Services
30.2.2.3. Strategy
30.2.2.4. Financial Performance
30.2.3. Celltrion Inc.
30.2.3.1. Overview
30.2.3.2. Products and Services
30.2.3.3. Strategy
30.2.3.4. Financial Performance
30.2.4. Cipla Inc.
30.2.4.1. Overview
30.2.4.2. Products and Services
30.2.4.3. Strategy
30.2.4.4. Financial Performance
30.2.5. F. Hoffmann-La Roche Ltd.
30.2.5.1. Overview
30.2.5.2. Products and Services
30.2.5.3. Strategy
30.2.5.4. Financial Performance

31. Global Antiviral Combination Therapy Market Competitive Benchmarking

32. Global Antiviral Combination Therapy Market Competitive Dashboard

33. Key Mergers And Acquisitions In The Antiviral Combination Therapy Market

34. Antiviral Combination Therapy Market Future Outlook and Potential Analysis
34.1 Antiviral Combination Therapy Market In 2028 - Countries Offering Most New Opportunities
34.2 Antiviral Combination Therapy Market In 2028 - Segments Offering Most New Opportunities
34.3 Antiviral Combination Therapy Market In 2028 - Growth Strategies
34.3.1 Market Trend Based Strategies
34.3.2 Competitor Strategies

35. Appendix
35.1. Abbreviations
35.2. Currencies
35.3. Historic And Forecast Inflation Rates
35.4. Research Inquiries
35.5. The Business Research Company
35.6. Copyright And Disclaimer

お買い物ガイド

よくある質問

この商品のレポートナンバー

0000037427

国内・海外の市場調査レポート販売

世界中の市場調査レポートを販売！当社に無いレポートもお探しします。